Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tropisetron with risperidone for schizophrenia

Trial Profile

Tropisetron with risperidone for schizophrenia

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Mar 2017

At a glance

  • Drugs Tropisetron (Primary) ; Risperidone
  • Indications Psychotic disorders; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Sep 2012 Status changed from recruiting to completed based on results in the American Journal of Psychiatry.
    • 01 Sep 2012 Results published in the American Journal of Psychiatry.
    • 12 Mar 2009 Planned end date changed from 1 Feb 2010 to 1 Apr 2010, based on information from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top